(Q38187576)

30 August 2017

title

Mouse models of glioblastoma: lessons learned and questions to be answered (English)

1 reference

30 August 2017

1 reference

1 reference

2

Jason Karamchandani

1 reference

30 August 2017

Loury Janbazian

1

1 reference

30 August 2017

Sunit Das

series ordinal

3

1 reference

30 August 2017

publication date

13 February 2014

1 reference

Journal of Neuro-Oncology

30 August 2017

published in

1 reference

30 August 2017

volume

118

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

1-8

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Cancer stem cells and glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Cre activity causes widespread apoptosis and lethal anemia during embryonic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Site- and time-specific gene targeting in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Malignant astrocytic glioma: genetics, biology, and paths to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Development of a novel mouse glioma model using lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Modeling Adult Gliomas Using RCAS/t-va Technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Pten haploinsufficiency accelerates formation of high-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Proliferation of human malignant astrocytomas is dependent on Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Role of platelet-derived growth factors in physiology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Links between mutant p53 and genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1401-X

An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

21 January 2018

1 reference

12 December 2020

Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice

1 reference

12 December 2020

PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells

1 reference

12 December 2020

Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model

1 reference

12 December 2020

Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.

1 reference

12 December 2020

Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.

1 reference

12 December 2020

Induction of neoplasms by viruses in marmoset monkeys.

1 reference

12 December 2020

10.1007/S11060-014-1401-X

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1005126992

0 references

1 reference